These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment. Ahmadi S; Seraj M; Chiani M; Hosseini S; Bazzazan S; Akbarzadeh I; Saffar S; Mostafavi E Int J Nanomedicine; 2022; 17():6233-6255. PubMed ID: 36531115 [TBL] [Abstract][Full Text] [Related]
8. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation. El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177 [TBL] [Abstract][Full Text] [Related]
9. Niosomal delivery of simvastatin to MDA-MB-231 cancer cells. Akbarzadeh I; Saremi Poor A; Yaghmaei S; Norouzian D; Noorbazargan H; Saffar S; Ahangari Cohan R; Bakhshandeh H Drug Dev Ind Pharm; 2020 Sep; 46(9):1535-1549. PubMed ID: 32808813 [TBL] [Abstract][Full Text] [Related]
11. Fabrication and Appraisal of Simvastatin via Tailored Niosomal Nanovesicles for Transdermal Delivery Enhancement: In Vitro and In Vivo Assessment. Salem HF; Kharshoum RM; Abou-Taleb HA; Farouk HO; Zaki RM Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33494472 [TBL] [Abstract][Full Text] [Related]
12. Green tea catechin loaded niosomes: formulation and their characterization for food fortification. Gadapa S; Battula SN; Mor S; Pushpadass HA; Naik LN; Emerald ME J Food Sci Technol; 2022 Sep; 59(9):3669-3682. PubMed ID: 35875240 [TBL] [Abstract][Full Text] [Related]
13. Cholesterol-Based Nanovesicles Enhance the In Vitro Cytotoxicity, Ex Vivo Intestinal Absorption, and In Vivo Bioavailability of Flutamide. Ali MA; Mohamed MI; Megahed MA; Abdelghany TM; El-Say KM Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834155 [TBL] [Abstract][Full Text] [Related]
14. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles. Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277 [TBL] [Abstract][Full Text] [Related]
15. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study. Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236 [TBL] [Abstract][Full Text] [Related]
16. Quality-by-Design-Assisted Optimization of Carvacrol Oil-Loaded Niosomal Gel for Anti-Inflammatory Efficacy by Topical Route. Ghazwani M; Hani U; Alam A; Alqarni MH Gels; 2023 May; 9(5):. PubMed ID: 37232993 [TBL] [Abstract][Full Text] [Related]
17. Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes. Shaker DS; Shaker MA; Hanafy MS Int J Pharm; 2015 Sep; 493(1-2):285-94. PubMed ID: 26200748 [TBL] [Abstract][Full Text] [Related]
18. Sorbitan ester niosomes for topical delivery of rofecoxib. Das MK; Palei NN Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223 [TBL] [Abstract][Full Text] [Related]
19. Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment. Basheer HA; Alhusban MA; Zaid Alkilani A; Alshishani A; Elsalem L; Afarinkia K Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894371 [TBL] [Abstract][Full Text] [Related]
20. Encapsulation of Leflunomide (LFD) in a novel niosomal formulation facilitated its delivery to THP-1 monocytic cells and enhanced Aryl hydrocarbon receptor (AhR) nuclear translocation and activation. Hasani M; Sani NA; Khodabakhshi B; Arabi MS; Mohammadi S; Yazdani Y Daru; 2019 Dec; 27(2):635-644. PubMed ID: 31432467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]